IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 22 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $590,063 | -92.1% | 577,000 | -90.9% | 0.01% | -89.4% |
| Q1 2022 | $7,438,494 | -12.0% | 6,333,000 | -15.0% | 0.05% | -6.0% |
| Q4 2021 | $8,454,708 | +185.4% | 7,450,000 | +204.1% | 0.05% | +127.3% |
| Q3 2021 | $2,962,555 | +7597.1% | 2,450,000 | +7105.9% | 0.02% | – |
| Q1 2021 | $38,489 | -98.5% | 34,000 | -98.5% | 0.00% | -100.0% |
| Q4 2020 | $2,502,527 | -50.9% | 2,201,000 | -57.2% | 0.02% | -64.3% |
| Q3 2020 | $5,098,000 | – | 5,146,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAMDEN ASSET MANAGEMENT L P /CA | 37,725,000 | $44,872,000 | 1.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,839,000 | $5,831,000 | 0.53% |
| AQR Arbitrage LLC | 13,500,000 | $16,193,000 | 0.46% |
| Context Capital Management, LLC | 3,934 | $4,719,000 | 0.44% |
| Polar Asset Management Partners Inc. | 7,000,000 | $8,387,000 | 0.09% |
| Calamos Advisors LLC | 9,500,000 | $11,397,000 | 0.05% |
| LINDEN ADVISORS LP | 6,998,000 | $8,394,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 16,318,000 | $19,572,000 | 0.02% |
| Citadel Advisors | 68,788,000 | $82,290,000 | 0.02% |
| PUTNAM INVESTMENTS LLC | 7,564,000 | $8,997,000 | 0.01% |